Navin Kumar Loganadan (Navin K Loganadan)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

Pharmacogenomics and personalized medicine

Clinical kidney journal

Pharmacogenomics

Diabetic medicine : a journal of the British Diabetic Association

Ministry of Health Malaysia

National University of Malaysia (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ministry of Health Malaysia Jun 15 2004

Malaysia

Clinical Pharmacist :: Pharmacy

Education History

National University of Malaysia Jul 01 2009 - Jun 30 2010

Malaysia

MSC :: Pharmacy

Publications

Abraham Degaga, Sisay Sirgu, Hasniza Zaman Huri, Maw Shin Sim, Navin Kumar Loganadan, Tedla Kebede, Birhanemeskel Tegene, Ephrem Engidawork, Workineh Shibeshi
Association of the Reduced Function Met420del Polymorphism of SLC22A1 with Metformin-Induced Gastrointestinal Intolerance in Ethiopian Patients with Type 2 Diabetes Mellitus. Pharmacogenomics and personalized medicine 17 (2024)
Abraham Degaga, Sisay Sirgu, Hasniza Zaman Huri, Maw Shin Sim, Navin Kumar Loganadan, Tedla Kebede, Birhanemeskel Tegene, Ephrem Engidawork, Workineh Shibeshi
Association of the Reduced Function Met420del Polymorphism of SLC22A1 with Metformin-Induced Gastrointestinal Intolerance in Ethiopian Patients with Type 2 Diabetes Mellitus. Pharmacogenomics and personalized medicine 17 (2024)
Ruth Sim, Chong Chun Wie, Navin Kumar Loganadan, Zanariah Hussein, Noor Lita Adam, Dr Shaun Wen Huey Lee
Impact of COVID-19 Lockdown on Glycemic, Weight, Blood Pressure Control and Medication Adherence in Patients with Type 2 Diabetes. Patient preference and adherence 17 (2023)
Abraham Degaga, Sisay Sirgu, Hasniza Zaman Huri, Maw Shin Sim, Tedla Kebede, Birhanemeskel Tegene, Navin Kumar Loganadan, Ephrem Engidawork, Workineh Shibeshi
Association of Met420del Variant of Metformin Transporter Gene SLC22A1 with Metformin Treatment Response in Ethiopian Patients with Type 2 Diabetes. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Ruth Sim, Chong Chun Wie, Navin Kumar Loganadan, Alan Yean-Yip Fong, Leenhapong Navaravong, Zanariah Hussein, Kamlesh Khunti F MedSci, Dr Shaun Wen Huey Lee
Comparative effectiveness of cardiovascular, renal and safety outcomes of second-line antidiabetic drugs use in people with type 2 diabetes: A systematic review and network meta-analysis of randomised controlled trials. Diabetic medicine : a journal of the British Diabetic Association 39 (3) (2022)
Ruth Sim, Chong Chun Wie, Navin Kumar Loganadan, Noor Lita Adam, Zanariah Hussein, Dr Shaun Wen Huey Lee
Comparison of a chronic kidney disease predictive model for type 2 diabetes mellitus in Malaysia using Cox regression versus machine learning approach. Clinical kidney journal 16 (3) (2022)
Ruth Sim, Chong Chun Wie, Navin Kumar Loganadan, Noor Lita Adam, Zanariah Hussein, Dr Shaun Wen Huey Lee
Comparison of a chronic kidney disease predictive model for type 2 diabetes mellitus in Malaysia using Cox regression versus machine learning approach. Clinical kidney journal 16 (3) (2022)
Navin Kumar Loganadan, Hasniza Zaman Huri, Shireene Ratna Vethakkan, Zanariah Hussein
Pharmacogenetics of sulfonylurea-induced hypoglycemia in Type 2 diabetes patients: the SUCLINGEN study. Pharmacogenomics 22 (16) (2021)
Navin Kumar Loganadan, Hasniza Zaman Huri, Shireene Ratna Vethakkan, Zanariah Hussein
Clinical and genetic predictors of secondary sulfonylurea failure in Type 2 diabetes patients: the SUCLINGEN study. Pharmacogenomics 21 (9) (2020)

Navin Kumar Loganadan.css-eqlu8i{font-size:small;padding-left:4px;} (Navin K Loganadan)

Publication Activity (10 Years)

Top Topics

Top Venues

Navin Kumar Loganadan (Navin K Loganadan)